wakix
bioprojet pharma - pitolisant - narkolepsia - muut hermoston huumeet - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
pramipexole sandoz 0.26 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 0.26 mg - pramipeksoli
pramipexole sandoz 0.52 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 0.52 mg - pramipeksoli
pramipexole sandoz 1.05 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 1.05 mg - pramipeksoli
pramipexole sandoz 1.57 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 1.57 mg - pramipeksoli
pramipexole sandoz 2.1 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 2.1 mg - pramipeksoli
pramipexole sandoz 2.62 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 2.62 mg - pramipeksoli
pramipexole sandoz 3.15 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 3.15 mg - pramipeksoli
parlodel 2.5 mg tabletti
meda oy - bromocriptinum,bromocriptini mesilas - tabletti - 2.5 mg - bromokriptiini
parlodel 10 mg kapseli, kova
meda oy - bromocriptini mesilas,bromocriptinum - kapseli, kova - 10 mg - bromokriptiini